Literature DB >> 18046579

Activation of stem cells in hepatic diseases.

T G Bird1, S Lorenzini, S J Forbes.   

Abstract

The liver has enormous regenerative capacity. Following acute liver injury, hepatocyte division regenerates the parenchyma but, if this capacity is overwhelmed during massive or chronic liver injury, the intrinsic hepatic progenitor cells (HPCs) termed oval cells are activated. These HPCs are bipotential and can regenerate both biliary epithelia and hepatocytes. Multiple signalling pathways contribute to the complex mechanism controlling the behaviour of the HPCs. These signals are delivered primarily by the surrounding microenvironment. During liver disease, stem cells extrinsic to the liver are activated and bone-marrow-derived cells play a role in the generation of fibrosis during liver injury and its resolution. Here, we review our current understanding of the role of stem cells during liver disease and their mechanisms of activation.

Entities:  

Mesh:

Year:  2007        PMID: 18046579      PMCID: PMC3034134          DOI: 10.1007/s00441-007-0542-z

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  184 in total

1.  Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes.

Authors:  Manuel Alvarez-Dolado; Ricardo Pardal; Jose M Garcia-Verdugo; John R Fike; Hyun O Lee; Klaus Pfeffer; Carlos Lois; Sean J Morrison; Arturo Alvarez-Buylla
Journal:  Nature       Date:  2003-10-12       Impact factor: 49.962

2.  Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetylamino-fluorene, and 3'-methyl-4-dimethylaminoazobenzene.

Authors:  E FARBER
Journal:  Cancer Res       Date:  1956-02       Impact factor: 12.701

3.  In vitro transdifferentiation of adult bone marrow Sca-1+ cKit- cells cocultured with fetal liver cells into hepatic-like cells without fusion.

Authors:  Yasuhiro Yamada; Eishi Nishimoto; Hiroaki Mitsuya; Yuji Yonemura
Journal:  Exp Hematol       Date:  2006-01       Impact factor: 3.084

4.  Proliferation of hepatic lineage cells of normal C57BL and interleukin-6 knockout mice after cocaine-induced periportal injury.

Authors:  D Rosenberg; Z Ilic; L Yin; S Sell
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

5.  Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection.

Authors:  Aileen Marshall; Simon Rushbrook; Susan E Davies; Lesley S Morris; Ian S Scott; Sarah L Vowler; Nicholas Coleman; Graeme Alexander
Journal:  Gastroenterology       Date:  2005-01       Impact factor: 22.682

6.  Bone marrow progenitors are not the source of expanding oval cells in injured liver.

Authors:  Anuradha Menthena; Niloyjyoti Deb; Michael Oertel; Petar N Grozdanov; Jaswinder Sandhu; Shalin Shah; Chandan Guha; David A Shafritz; Mariana D Dabeva
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

7.  Expression of stromal cell-derived factor-1 and of its receptor CXCR4 in liver regeneration from oval cells in rat.

Authors:  Philippe Mavier; Nadine Martin; Dominique Couchie; Anne-Marie Préaux; Yannick Laperche; Elie Serge Zafrani
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

8.  Activation of hepatic stem cell compartment in the rat: role of transforming growth factor alpha, hepatocyte growth factor, and acidic fibroblast growth factor in early proliferation.

Authors:  R P Evarts; Z Hu; K Fujio; E R Marsden; S S Thorgeirsson
Journal:  Cell Growth Differ       Date:  1993-07

9.  The differential effects of three forms of interferon alfa on hepatic regeneration after partial hepatectomy in the rat.

Authors:  S Wong; T Gauthier; K D Kaita; G Y Minuk
Journal:  Hepatology       Date:  1995-09       Impact factor: 17.425

10.  Antigenic relationship between oval cells and a subpopulation of hepatic foci, nodules, and carcinomas induced by the "resistant hepatocyte" model system.

Authors:  R A Faris; B A Monfils; H A Dunsford; D C Hixson
Journal:  Cancer Res       Date:  1991-02-15       Impact factor: 12.701

View more
  60 in total

1.  Foxl1-Cre-marked adult hepatic progenitors have clonogenic and bilineage differentiation potential.

Authors:  Soona Shin; Gabriel Walton; Reina Aoki; Karrie Brondell; Jonathan Schug; Alan Fox; Olga Smirnova; Craig Dorrell; Laura Erker; Andrew S Chu; Rebecca G Wells; Markus Grompe; Linda E Greenbaum; Klaus H Kaestner
Journal:  Genes Dev       Date:  2011-06-01       Impact factor: 11.361

2.  New concepts in liver regeneration.

Authors:  Kimberly J Riehle; Yock Y Dan; Jean S Campbell; Nelson Fausto
Journal:  J Gastroenterol Hepatol       Date:  2011-01       Impact factor: 4.029

3.  Liver regeneration, stem cells and beyond.

Authors:  Marcelo Af Ribeiro
Journal:  World J Gastrointest Surg       Date:  2009-11-30

Review 4.  Biology of the adult hepatic progenitor cell: "ghosts in the machine".

Authors:  Houda Darwiche; Bryon E Petersen
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

5.  Transdetermination: a new trend in cellular reprogramming.

Authors:  Rohan Manohar; Eric Lagasse
Journal:  Mol Ther       Date:  2009-06       Impact factor: 11.454

Review 6.  Elucidating the metabolic regulation of liver regeneration.

Authors:  Jiansheng Huang; David A Rudnick
Journal:  Am J Pathol       Date:  2013-10-17       Impact factor: 4.307

Review 7.  Stages based molecular mechanisms for generating cholangiocytes from liver stem/progenitor cells.

Authors:  Wei-Hui Liu; Li-Na Ren; Tao Chen; Li-Ye Liu; Li-Jun Tang
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

8.  FGF7 is a functional niche signal required for stimulation of adult liver progenitor cells that support liver regeneration.

Authors:  Hinako M Takase; Tohru Itoh; Seitaro Ino; Ting Wang; Takehiko Koji; Shizuo Akira; Yasuhiro Takikawa; Atsushi Miyajima
Journal:  Genes Dev       Date:  2013-01-15       Impact factor: 11.361

9.  Immunohistochemical evaluation of hepatic oval cell activation and differentiation toward pancreatic beta-cell phenotype in streptozotocin-induced diabetic mice.

Authors:  M Vorobeychik; K Bloch; R Zemel; L Bachmetov; R Tur-Kaspa; P Vardi
Journal:  J Mol Histol       Date:  2008-07-31       Impact factor: 2.611

10.  Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver.

Authors:  Li Lu; Ying Li; Soo Mi Kim; Wouter Bossuyt; Pu Liu; Qiong Qiu; Yingdi Wang; Georg Halder; Milton J Finegold; Ju-Seog Lee; Randy L Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.